Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis

Minoo Battiwalla1, Yiyuan Wu, Rajinder P S Bajwa

  • 1Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14202, USA. minoo.battiwalla@roswellpark.org <minoo.battiwalla@roswellpark.org>

Insights

Ganciclovir effectively prevents cytomegalovirus (CMV) disease after stem cell transplants but may harm immune recovery. This antiviral drug suppresses T-lymphocyte proliferation, potentially impacting long-term transplant outcomes.

Area of Science:

  • Immunology
  • Hematology
  • Virology

Background:

  • Cytomegalovirus (CMV) disease mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients has decreased due to ganciclovir. However, ganciclovir has not improved overall survival and recurrent CMV antigenemia predicts malignancy relapse.
  • Prolonged ganciclovir exposure is linked to increased relapse rates in HSCT patients, suggesting potential negative impacts beyond CMV control.

Purpose of the Study:

  • To investigate the hypothesis that ganciclovir negatively affects immune reconstitution post-HSCT.
  • To determine the in vitro effect of ganciclovir on normal human T-lymphocyte activation and proliferation.

Main Methods:

  • Assessed T-lymphocyte activation and proliferation using PHA-induced (3)H-thymidine uptake.
  • Measured the impact of ganciclovir and foscarnet at therapeutic concentrations on lymphocyte responses.
  • Evaluated ganciclovir's effect on bromodeoxyuridine incorporation, lymphocyte survival, and apoptosis.

Main Results:

  • Therapeutic concentrations of ganciclovir significantly reduced T-lymphocyte activation and proliferation.
  • Ganciclovir impaired DNA synthesis in proliferating lymphocytes, as indicated by reduced bromodeoxyuridine incorporation.
  • Foscarnet did not exhibit the same suppressive effect on T-lymphocyte proliferation at tested concentrations. Ganciclovir did not induce lymphocyte apoptosis or impair survival.

Conclusions:

  • Ganciclovir suppresses T-lymphocyte proliferation in vitro by inhibiting DNA synthesis.
  • These findings suggest ganciclovir may have detrimental implications for T-lymphocyte function and immune reconstitution following allogeneic bone marrow transplantation (BMT).
  • Further research is warranted to explore strategies to mitigate ganciclovir's impact on immune recovery in HSCT recipients.

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...